The 31 references in paper D. Polyakov S., O. Domashenko M., P. Beloborodov V., K. Syssoev A., M. Shavlovsky M., Areg Totolian A., Д. Поляков С., О. Домашенко М., П. Белобородов В., К. Сысоев А., М. Шавловский М., Арег Тотолян А. (2014) “СОДЕРЖАНИЕ ЦИТОКИНОВ В ПЛАЗМЕ КРОВИ БОЛЬНЫХ, НАХОДЯЩИХСЯ НА ХРОНИЧЕСКОМ ГЕМОДИАЛИЗЕ // PLASMA CYTOKINES LEVELS IN PATIENTS UNDERGOING LONG-TERM HAEMODIALYSIS” / spz:neicon:mimmun:y:2011:i:3:p:211-218

1
Поляков Д.С., Грудинина Н.А., Соловьев К.В., Егоров В.В., Сироткин А.К., Алейникова Т.Д., Тотолян Арег А., Шавловский М.М. Бета-2-микроглобулиновый амилоидоз: фибриллогенез природного и рекомбинантных бета-2микроглобулинов человека // Медицинский академический журнал. – 2010. – Т. 10, No 2. – С. 4049.
(check this in PDF content)
2
Поляков Д.С., Тотолян Арег А., Шавловский М.М. Получение природного бета2микроглобулина человека // Молекулярная медицина. – 2010. – No 6. – С. 39-43.
(check this in PDF content)
3
Соловьев К.В., Грудинина Н.А., Семернин Е.Н., Морозова В., Смирнова С.А., Поляков Д.С., Алейникова Т.Д., Шляхто Е.В., Гудкова А.Я., Шавловский М.М. Мутации V30M, H90N и del9 в гене транстиретина у больных с кардиомиопатиями в Санкт-Петербурге // Генетика. – 2011. – Т. 47, No 2. – С. 1-7.
(check this in PDF content)
4
Шило В. Позднее осложнение программного гемодиализа: бета 2-микроглобулиновый амилоидоз. В. Шило, А. Денисов // Врач: Ежемесячный научно-практический и публицистический журнал. – 2002. – No 6. – С. 7-12.
(check this in PDF content)
5
Benz R.L., Siegfried J.W., Teehan B.P. Carpal tunnel syndrome in dialysis patients: Comparison between continuous ambulatory peritoneal dialysis and hemodialysis populations // Am. J. Kidney Dis. – 1988. – N 11. – Р. 473-476.
(check this in PDF content)
6
Campistol J.M., Sole M., Munoz-Gomez J., Lopez-Pedret J., Revert L. Systemic involvement of dialysis-amyloidosis // Am. J. Nephrol. – 1990. – N 10. – Р. 389-396.
(check this in PDF content)
7
Cavaillon J.M., Poignet J.L., Fitting C., Delons S. Serum interleukin-6 in long-term hemodialyzed patients // Nephron. – 1992. – 60. – Р. 307-313.
(check this in PDF content)
8
Cornelis F., Bardin T., Faller B. et al. Rheumatic syndromes and beta 2-microglobulin amyloidosis in patients receiving long-term peritoneal dialysis // Arthritis Rheum. – 1989. – N 32. – Р. 785-788.
(check this in PDF content)
9
Descamps-Latscha B., Herbelin A., Nguyen A.T. et al. Balance between IL-1 beta, TNF-α, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes // J. Immunol. – 1995. – 154. – Р. 882-892.
(check this in PDF content)
10
Gal R., Korzets A., Schwartz A., RathWolfson L., Gafter U. Systemic distribution of beta 2-microglobulin-derived amyloidosis in patients who undergo long-term hemodialysis. Report of seven cases and review of the literature // Arch. Pathol. Lab. Med. – 1994. – N 118. – Р. 718-721.
(check this in PDF content)
11
Herbelin A., Urena P., Nguyen A.T., Zingraff J., Descamps-Latscha B. Elevated circulating levels of interleukin-6 in patients with chronic renal failure // Kidney Int. – 1991. – 39. – Р. 954-960.
(check this in PDF content)
12
Jadoul M., Garbar C., Noёl H., Sennesael J., Vanholder R., Bernaert P., Rorive G., Hanique G., van Ypersele, de Strihou C. Histological prevalence of beta 2-microglobulin amyloidosis in hemodialysis: a prospective post-mortem study // Kidney Int. – 1997. – Jun; 51 (6). – Р. 1928-1932.
(check this in PDF content)
13
Kaizu Y., Kimura M., Yoneyama T. et al. Interleukin-6 may mediate malnutrition in chronic hemodialysis patients // Am. J. Kidney Dis. – 1998. – 31. – Р. 93-100.
(check this in PDF content)
14
Ketteler M., Koch K.M., Floege J. Imaging techniques in the diagnosis of dialysis-related amyloidosis // Semin Dial. – 2001. – Mar-Apr; 14 (2). – Р. 90-3.
(check this in PDF content)
15
Kimmel P.L., Phillips T.M., Simmens S.J. et al. Immunologic function and survival in hemodialysis patients // Kidney Int. – 1998. – 54. – Р. 236-244.
(check this in PDF content)
16
Libetta C., De Nicola L., Rampino T., De Simone W., Memoli B. Inflammatory effects of peritoneal dialysis: evidence of systemic monocyte activation //Kidney Int. – 1996. – 49. – Р. 506-511.
(check this in PDF content)
17
Loughrey C.M., Young I.S., Lightbody J.H., McMaster D., McNamee P.T., Trimble E.R. Oxidative stress in haemodialysis // QJM87. – 1994. – Р. 679-683.
(check this in PDF content)
18
Massry S.G., Coburn J.W. Guideline 10. β2-microglobulin amyloidosis // Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease / American Journal of Kidney Diseases. – 2003. – Vol. 42, Suppl 3. – P. 1-202.
(check this in PDF content)
19
Miyata T., van Ypersele de Strihou C., Kurokawa K., Baynes J.W. Alterations in nonenzymatic biochemistry in uremia: origin and significance of ‘‘carbonyl stress’’ in long-term uremic complications // Kidney Int. – 1999. – 55. – Р. 389399.
(check this in PDF content)
20
McGrath LT., Douglas A.F., McClean E., Brown J.H., Doherty C.C., Johnston G.D., Archbold G.P. Oxidative stress and erythrocyte membrane fluidity in patients undergoing regular dialysis // Clin. Chim. Acta. – 1995. – N 235. – Р. 179-188.
(check this in PDF content)
21
Moriniere P., Marie A., el Esper N., Fardellone P., Deramond H., Remond A., Sebert J.L., Fournier A. Destructive spondyloarthropathy with beta 2-microglobulin amyloid deposits in a uremic patient before chronic hemodialysis // Nephron. – 1991. – N 59. – Р. 654-657.
(check this in PDF content)
22
Naugle K., Darby M.L., Bauman D.B., Lineberger L.T., Powers R. The oral health status of individuals on renal dialysis // Ann Periodontol. – 1998. – N 3. – Р. 197-205.
(check this in PDF content)
23
Odetti P., Cosso L., Pronzato M.A., Dapino D., Gurreri G. Plasma advanced glycosylation endproducts in maintenance haemodialysis patients // Nephrol Dial Transplant. – 1995. – Nov. 10 (11). – Р. 2110-2113.
(check this in PDF content)
24
Ohashi K., Hara M., Kawai R., Ogura Y., Honda K., Nihei H., Mimura N. Cervical discs are most susceptible to beta 2-microglobulin amyloid deposition in the vertebral column // Kidney Int. – 1992. – N 41. – Р. 1646-1652.
(check this in PDF content)
25
Palestro C.J., Vega A., Kim C.K., Vallabhajosula S., Goldsmith S.J. Indium-111-labeled leukocyte scintigraphy in hemodialysis access-site infection // J. NuclMed. – 1990. – N 31. – Р. 319324.
(check this in PDF content)
26
Pereira B.J., Shapiro L., King A.J., Falagas M.E., Strom J.A., Dinarello C.A. Plasma levels of IL-1 beta, TNF-α and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients // Kidney Int. – 1994. – N 45. – Р. 890-896.
(check this in PDF content)
27
Pereira B.J., Snodgrass B.R., Hogan P.J., King A.J. Diffusive and convective transfer of cytokine-inducing bacterial products across hemodialysis membranes // Kidney Int. – 1995. – N 47. – Р. 603-610.
(check this in PDF content)
28
Sheikh-Hamad D., Ayus J.C. The patient with a clotted PTFE graft developing fever // Nephrol Dial Transplant. – 1998. – N 13. – Р. 2392-2393.
(check this in PDF content)
29
Sprague S.M., Moe S.M. Clinical manifestations and pathogenesis of dialysis-related amyloidosis // Semin Dial. – 1996. – N 9. – Р. 360369.
(check this in PDF content)
30
Varela M.P., Kimmel P.L., Phillips T.M. et al. Biocompatibility of hemodialysis membranes: interrelations between plasma complement and cytokine levels // Blood Purif. – 2001. – N 19. – Р. 370-379.
(check this in PDF content)
31
Zingraff J.J., Noel L.H., Bardin T., Atienza C., Zins B., Drueke T.B., Kuntz D. Beta 2-microglobulin amyloidosis in chronic renal failure // N. Engl J. Med. – 1990. – N 323. – Р. 1070-1071. поступила в редакцию 05.02.2011
(check this in PDF content)